MOSCOW, Sept 2 (Reuters) - Russia's Gazprom has agreed to a modest rise in gas supplies to China via an existing pipeline and has signed a memorandum on building the vast Power of Siberia 2 pipeline.
Rapport Therapeutics, Inc.'s RAP-219 delivered impressive Phase 2a results in drug-resistant focal onset seizures, driving Rapport Therapeutics' stock up over 135% and boosting investor optimism. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback